Avenir Wellness Solutions, Inc. (AVRW)
- Previous Close
0.0388 - Open
0.0332 - Bid --
- Ask --
- Day's Range
0.0330 - 0.0439 - 52 Week Range
0.0230 - 0.2500 - Volume
15,167 - Avg. Volume
21,022 - Market Cap (intraday)
3.214M - Beta (5Y Monthly) -0.46
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date Jul 26, 2024 - Jul 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products in beauty, health and wellness, and pet care categories under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. The company sells its products through drug and grocery chains, convenience stores, and mass retailers. It also offers its products under private label to retailers and multi-level marketers, as well as DTC, via online website orders. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in October 2022. Avenir Wellness Solutions, Inc. was founded in 2011 and is headquartered in Sherman Oaks, California.
www.avenirwellness.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: AVRW
Performance Overview: AVRW
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVRW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVRW
Valuation Measures
Market Cap
3.21M
Enterprise Value
11.53M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.76
Price/Book (mrq)
--
Enterprise Value/Revenue
2.79
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-255.34%
Return on Assets (ttm)
-50.00%
Return on Equity (ttm)
--
Revenue (ttm)
4.14M
Net Income Avi to Common (ttm)
-10.56M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
189k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.58M
Research Analysis: AVRW
Company Insights: AVRW
AVRW does not have Company Insights